Cost-effectiveness Analysis of Three Corticosteroids in ILDs
Status:
Completed
Trial end date:
2020-03-15
Target enrollment:
Participant gender:
Summary
This was a 3 months prospective, open label, and parallel study to test the efficacy of 3
different corticosteroids in the management of interstitial lung diseases. Followed by a
pharmacoeconomic analysis to find which regimen (betamethasone, dexamethasone or
prednisolone) is the most cost-effective.